11 results
diabetes endocrinology cardiology dpp4 management sglt2 summary acyclovir agonists allopurinol anthracycline antidote binder cardiotoxicity chemotherapy ddi drugdrug glp1 gout her2
SGLT2 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors ... - Pharmacology ... of use) Common Side ... #Pharmacology # ... Summary #DM2 #diabetes
DPP4 Inhibitors - Normal and Renal Dosing Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Normal and Renal Dosing ... with only few side ... #Renal #Dosing ... #Pharmacology #Management ... #Diabetes #DM2
Acyclovir - Pharmacology Summary • Mechanism of Action: Nucleoside analog - selectively inhibits viral replication of
Acyclovir - Pharmacology ... - selectively inhibits ... against CMV) • Dosing ... Resistance • Toxicity ... #Acyclovir #Pharmacology
DPP-4 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
DPP-4 Inhibitors ... - Pharmacology ... failure Common Side ... #Pharmacology # ... Summary #DM2 #diabetes
SGLT2 Inhibitors SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
SGLT2 Inhibitors ... SGLT2 inhibitors ... drugs include side ... #Pharmacology # ... Medications #DM2
GLP-1 Agonists Adlyxin (Lixisenatide) Daily Bydureon (Exenatide ER) Weekly Ozempic (Semaglutide) Weekly Trulicity (Dulaglutide) Weekly Victoza (Liraglutide) Daily
Common side effects ... GLP1 #Agonists #Pharmacology ... #Dosing #Diabetes ... #DM2 #Endocrinology
Veltassa (Patiromer) MECHANISM: Potassium Binder INDICATION: Treatment of Hyperkalemia FORMULATION: Powder for oral suspension DOSING: 8.4
oral suspension DOSING ... ACE inhibitors, ... Most common side ... #Hyperkalemia #Pharmacology
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products Angiotensin-Converting Enzyme Inhibitors (ACEIs) • Night-blooming
Angiotensin-Converting Enzyme Inhibitors ... risk of digoxin toxicity ... increasing risk for toxicity ... Monoamine Oxidase Inhibitors ... supplementals #herbal #pharmacology
Allopurinol Pharmacology Summary Xanthine oxidase inhibitor blocking the formation of new uric acid Initiate 1-2 days prior to
Allopurinol Pharmacology ... Xanthine oxidase inhibitor ... chemotherapy Dosing ... : 100 mg/m2/dose ... CrCl <10mL/min Side
Methotrexate Toxicology Intravenous leucovorin (folinic acid) treatment serves as a cofactor necessary for synthesis of thymidylate
ineffective because MTX inhibits ... Leucovorin dosing ... , up to 100 mg/m2 ... evidence of marrow toxicity ... #Management #Pharmacology
No results found for "Wide pocus pharmacology pulmonaryembolism dm2 inhibitors dosing toxicity"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Wide #pocus #pharmacology #pulmonaryembolism #dm2 #inhibitors #dosing #toxicity